<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To test the hypothesis that age of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> <z:hpo ids='HP_0003674'>onset</z:hpo> influences inherent susceptibility to diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, independent of disease duration and degree of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: <z:hpo ids='HP_0000488'>Retinopathy</z:hpo> data from 624 patients with a type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> duration of 20-30 years (group A) were analyzed by stratifying patients according to <z:hpo ids='HP_0011007'>age of onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp> and glycemic control </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000488'>Retinopathy</z:hpo> status was scored clinically as per a modified Early Treatment Diabetic <z:hpo ids='HP_0000488'>Retinopathy</z:hpo> Study (ETDRS) severity scale </plain></SENT>
<SENT sid="3" pm="."><plain>To obviate possible bias due to a higher attrition from comorbidities in those with later-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, 852 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> of shorter duration (10-12 years, group B) were similarly studied </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Prevalence and severity of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> was significantly higher in the younger-<z:hpo ids='HP_0003674'>onset</z:hpo>, group A patients </plain></SENT>
<SENT sid="5" pm="."><plain>When further stratified according to mean A1C, <z:hpo ids='HP_0000488'>retinopathy</z:hpo> risk remained increased in younger-<z:hpo ids='HP_0003674'>onset</z:hpo> patients </plain></SENT>
<SENT sid="6" pm="."><plain>The greatest impact was seen in those with a mean A1C &gt;9% (odds ratio [OR] for <z:hpo ids='HP_0000488'>retinopathy</z:hpo> 16.6, 7.5, and 2.7 for age of diagnosis &lt;45, 45-55, and &gt;55 years, respectively, P = 0.003) </plain></SENT>
<SENT sid="7" pm="."><plain>By logistic regression, earlier type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> <z:hpo ids='HP_0003674'>onset</z:hpo> is associated with increased <z:hpo ids='HP_0000488'>retinopathy</z:hpo> risk, independent of traditional risk factors (OR of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> 1.9, 1.1, and 1 for <z:hpo ids='HP_0011007'>age of onset</z:hpo> &lt;45, 45-55, and &gt;55 years, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>Similar results were found in group B patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These data suggest an increased inherent susceptibility to diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> with earlier-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>This further supports the importance of delaying development of <z:mp ids='MP_0002055'>diabetes</z:mp> and also implies a need for more stringent metabolic targets for younger individuals </plain></SENT>
</text></document>